13807-17-5

Basic information

• Product Name: 5-Thiazolecarboxylic acid, 4-amino-2-(phenylamino)-, methyl ester
• CAS NO: 13807-17-5
• Molecular Formula: C11H11N3O2S
• Molecular Weight: 249.293
• Mol File: 13807-17-5.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 5-Thiazolecarboxylic acid, 4-amino-2-(phenylamino)-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 5-Thiazolecarboxylic acid, 4-amino-2-(phenylamino)-, methyl ester(13807-17-5)
• EPA Substance Registry System: 5-Thiazolecarboxylic acid, 4-amino-2-(phenylamino)-, methyl ester(13807-17-5)

Safety Data

• Hazardous Substances Data: 13807-17-5(Hazardous Substances Data)

Upstream product

• 41835-08-9 N-cyano-N'-phenylthiourea 
• 96-34-4 methyl chloroacetate 
• 13807-07-3 (4-oxo-3-phenyl-thiazolidin-2-ylidene)-cyanamide 
• 124-41-4 sodium methylate 
• 420-04-2 CYANAMID 
• 103-72-0 phenyl isothiocyanate 

Downstream Products

• 14998-02-8 2-(phenylamino)thiazolo[4,5-d]pyrimidin-7(6H)-one 

Relevant articles and documents

Synthesis and evaluation of 2,7-diamino-thiazolo[4,5-d] pyrimidine analogues as anti-tumor epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors

2,7-Diamino-thiazolo[4,5-d]pyrimidine analogues were synthesized as novel epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors. Representative compounds showed potent and selective EGFR inhibitory activities and inhibited in vitro cellular p

Use of 2,4-diaminothiazole derivatives

2,4-Diaminothiazole derivatives which inhibit GSK-3 (glycogen synthase kinase-3) and which are useful for the treatment and/or prevention disorders and diseases wherein an inhibition of GSK-3 is beneficial, especially especially Alzheimer's disease, bipolar disorder, IGT (impaired glucose tolerance), Type 1 diabetes, Type 2 diabetes and obesity.